Zobrazeno 1 - 4
of 4
pro vyhledávání: '"R. Ranjith Kumar"'
Autor:
Rajasekaran S; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.; The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Siddiqui J; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.; The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Rakijas J; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.; The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Nicolay B; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.; Harvard Medical School, Boston, MA, USA.; Agios Pharmaceutical, Cambridge, MA, USA., Lin C; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.; The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Khan E; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.; The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Patel R; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.; The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Morris R; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.; Harvard Medical School, Boston, MA, USA., Wyler E; Berlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Boukhali M; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.; Harvard Medical School, Boston, MA, USA., Balasubramanyam J; Department of Nanobiotechnology, Vision Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India., Ranjith Kumar R; Department of Nanobiotechnology, Vision Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India., Van Rechem C; Department of Pathology, Stanford University, Stanford, CA, USA., Vogel C; Center for Genomics and Systems Biology, Department of Biology, New York University, New York, USA., Elchuri SV; Department of Nanobiotechnology, Vision Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India., Landthaler M; Berlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Obermayer B; Berlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; IRI Life Sciences, Institute für Biologie, Humboldt Universität zu Berlin, Berlin, Germany.; Core Unit Bioinformatics, Berlin Institute of Health (BIH), Berlin, Germany., Haas W; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.; Harvard Medical School, Boston, MA, USA., Dyson N; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA. dyson@helix.mgh.harvard.edu.; Harvard Medical School, Boston, MA, USA. dyson@helix.mgh.harvard.edu., Miles W; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA. wayne.miles@osumc.edu.; The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. wayne.miles@osumc.edu.
Publikováno v:
Communications biology [Commun Biol] 2021 Aug 17; Vol. 4 (1), pp. 977. Date of Electronic Publication: 2021 Aug 17.
Autor:
Rahi Patel, Wayne O. Miles, R. Ranjith Kumar, Wilhelm Haas, Brandon Nicolay, Chenyu Lin, Benedikt Obermayer, Robert Morris, Capucine Van Rechem, Myriam Boukhali, Emanuel Wyler, Nicholas J. Dyson, Swetha Rajasekaran, Jessica B. Rakijas, Eshan Khan, Christine Vogel, Markus Landthaler, Jayashree Balasubramanyam, Jalal K. Siddiqui, Sailaja Elchuri
Publikováno v:
Communications Biology
Communications Biology, Vol 4, Iss 1, Pp 1-1 (2021)
Communications Biology, Vol 4, Iss 1, Pp 1-1 (2021)
Inactivation of RB is one of the hallmarks of cancer, however gaps remain in our understanding of how RB-loss changes human cells. Here we show that pRB-depletion results in cellular reprogramming, we quantitatively measured how RB-depletion altered
Autor:
Wayne O. Miles, Capucine Van Rechem, Swetha Rajasekaran, Jalal K. Siddiqui, Sailaja Elchuri, R. Ranjith Kumar, Christine Vogel, Jayashree Balasubramanyam, Robert Morris, Wilhelm Haas, Rahi Patel, Jessica B. Rakijas, Markus Landthaler, Myriam Boukhali, Benedikt Obermayer, Eshan Khan, Emanuel Wyler, Nicholas J. Dyson, Brandon Nicolay, Chenyu Lin
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021)
Communications Biology
Communications Biology
Inactivation of RB is one of the hallmarks of cancer, however gaps remain in our understanding of how RB-loss changes human cells. Here we show that pRB-depletion results in cellular reprogramming, we quantitatively measured how RB-depletion altered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdbad3217b9b0a54197007fc429cb148
http://edoc.mdc-berlin.de/20853/1/20853oa.pdf
http://edoc.mdc-berlin.de/20853/1/20853oa.pdf
Autor:
Amit Chatterjee, Sonalisa Pandey, Vikas Khetan, R Ranjith Kumar, Debashis Sahoo, Sailaja Elchuri, Pukhraj Rishi, Ravikanth Danda, S Maheswari, Sundara Ramaprabhu
Retinoblastoma (RB) is a good model to study drug resistance to cell-cycle inhibitors because it is driven by mutations in the core components of cell-cycle, i.e, Rb gene. However, there is limited gene expression dataset in RB which has major reprod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::134cebc2b4e2dfd18c445fa08a46bbb5
https://doi.org/10.1101/2021.02.17.431607
https://doi.org/10.1101/2021.02.17.431607